Bracken Sharon J 4
4 · ABBOTT LABORATORIES · Filed Feb 26, 2019
Insider Transaction Report
Form 4
Bracken Sharon J
Senior Vice President
Transactions
- Award
Common shares without par value
2019-02-22+17,292→ 56,321 total - Award
Option (right to buy)
2019-02-22+90,642→ 90,642 totalExercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common shares (90,642 underlying)
Holdings
- 760(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 22, 2019.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,214 on February 22, 2020, 30,214 on February 22, 2021, and 30,214 on February 22, 2022.